Guardian Point Capital, a firm known for its keen eye on high-quality compounders and alternative asset managers, has significantly expanded its position in Ryan Specialty Holdings (RYAN). According to an SEC filing dated May 15, 2026, the investment fund purchased an additional 75,000 shares in the first quarter, representing an estimated $3.20 million trade based on the quarter's average pricing.
This latest move brings Guardian Point Capital’s total stake in Ryan Specialty to 575,000 shares. The decision is particularly striking given Ryan Specialty's recent stock performance; as of May 14, 2026, its shares were priced at $31.20, marking a steep 55% decline over the past year. This downturn starkly contrasts with the S&P 500's robust 28% gain in the same period, indicating a strong contrarian belief from Guardian Point Capital.
Guardian Point’s Strategic Vision
Guardian Point Capital's portfolio reflects a preference for resilient assets, with top holdings including Apollo (NYSE: APO) at $55.71 million (23.0% of AUM), Alphabet (NASDAQ: GOOGL) at $28.69 million (11.8% of AUM), gold ETF SGOL (NYSEMKT: SGOL) at $26.77 million (11.0% of AUM), Amazon (NASDAQ: AMZN) at $26.03 million (10.7% of AUM), and ONTO (NYSE: ONTO) at $22.56 million (9.3% of AUM). Their latest investment in Ryan Specialty, despite recent market turbulence for the stock, aligns with their philosophy of identifying fundamentally strong companies that may be temporarily undervalued.
Ryan Specialty Holdings, Inc. specializes in providing unique insurance products and solutions, spanning distribution, underwriting, product development, administration, and risk management. The company operates effectively as both a wholesale broker and a managing underwriter, serving insurance brokers, agents, and carriers in search of specialized expertise and solutions.
Despite its stock's struggles, Ryan Specialty posted an impressive first quarter for 2026. Revenue soared 15.2% year over year to $795.2 million, with organic revenue growth reaching a healthy 11.8%. Adjusted EBITDAC climbed 15.7% to $232 million, and adjusted earnings per share saw a significant 20.5% increase to $0.47. Crucially, the company shifted from a loss a year earlier to a $40.6 million profit, underscoring its operational strength.
Management expressed confidence in navigating a tougher insurance market. Founder Patrick Ryan highlighted the firm's “diversified enterprise,” while CEO Tim Turner pointed to ongoing strategic investments in technology, AI, and data capabilities designed to solidify its competitive advantages. This proactive approach, coupled with sustained double-digit organic growth, suggests Ryan Specialty is well-positioned to continue gaining market share.
Investor Implications of Guardian Point’s Bet
Guardian Point Capital’s substantial investment suggests a strong belief in Ryan Specialty’s long-term value. The fund appears to view the recent decline in RYAN's stock as an opportunity rather than a red flag, capitalizing on what it perceives as a temporary misalignment between the company's robust operational performance and its market valuation. For other investors, this move signals that Ryan Specialty, with its TTM revenue of $3.16 billion and net income of $108.69 million, could be poised for a recovery, making its 1.6% dividend yield an even more appealing prospect.
